| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Medical Officer
1 company
White Mark Andrew is a See Remarks at ROCKET PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $239K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2024 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 3,080 | $16.63 | $51,205.00 | -4.3% | -37.5% | -77.4% | |
| Jul 8, 2024 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 3,026 | $20.40 | $61,715.27 | -4.0% | -18.8% | -85.7% | |
| Apr 8, 2024 | RCKT Rocket Pharmaceuticals, Inc. | See Remarks | Sell | 12,532 | $24.64 | $308,763.42 | -14.3% | -15.3% | -80.4% |